Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 309
- 试验地点
- 1
- 主要终点
- assess the proportion of vaccinated subjects in our cohort of cancer patients undergoing active cancer treatment
研究概览
简要总结
Cancer patients have a well-known and higher risk of vaccine-preventable disease (VPD) than the general population. VPD can cause serious complications due to compromised immune system, malnutrition and the same oncology treatments and represent a severe financial burden with a delay in treating the underlying cancer The main purpose of this survey is to analyse the perception of cancer patients on the topic vaccines and vaccine-preventable diseases, the acceptability of vaccines and the evaluation of the determining factors associated with the choice of the patient to be vaccinated or not. This information will be used to improve the management of these issues.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •>18 years of age;
- •Oncology patient defined as a patient with solid tumors undergoing active systemic treatment or follow-up;
- •Written informed consent
排除标准
- •Patients with hematological tumors
- •Patients who are unable to understand informed consent document
结局指标
主要结局
assess the proportion of vaccinated subjects in our cohort of cancer patients undergoing active cancer treatment
时间窗: 3 months
The primary endpoint will be to assess the proportion of vaccinated subjects in the investigators cohort of cancer patients undergoing active cancer treatment (number of patients who received at least one vaccine/ total number of patients)
次要结局
- assess the proportion of vaccinated subjects with the anti flu vaccine in the investigators cohort of cancer patients undergoing active cancer treatment(3 months)
- assess the proportion of vaccinated subjects with anti SARS-CoV-2 vaccine in the investigators cohort of cancer patients undergoing active cancer treatment(3 months)
- assess the proportion of vaccinated subjects with anti pneumococccal vaccine in the investigators cohort of cancer patients undergoing active cancer treatment(3 months)
- assess the proportion of vaccinated subjects with anti HZ vaccine in the investigators cohort of cancer patients undergoing active cancer treatment(3 months)
- assess which variables (sex, age, degree of education, marital state, commodities, type of tumor, type of oncological treatment) are associated with not willingness to receive vaccines(3 months)
研究者
Angioletta Lasagna
MD
Fondazione IRCCS Policlinico San Matteo di Pavia